Mañana empiezan las clases de epidemiología. Pondré esta figura. Tenemos suerte de tener una sanidad pública universal

En el dia mundial del #CCA es presenta ATUBIVI, l'associació de pacients! cadenaser.com/nacional/2024/…

Incredible piece of work from Meritxell Rovira Jennifer Bailey-Lundberg and colleagues - this resource will be widely used. A functional map of the ENTIRE normal ductal epithelium from centroacinar cells to main duct, identifying both the transcriptomic heterogeneity to organoid forming

What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at #AACR24, out in Cancer Discovery today rb.gy/q484j9 Tweetorial👇

Stunning interim clinical trial data from Revolution Medicines... PFS = 8.1 mo in 2nd line KRAS G12-mutant metastatic #PDAC. OS not yet reached, but already more than a year! Benchmark PFS for this group is 2-3.5 months, behnchmark OS is 6.1-6.9. 1/

📍TTD-Registro Español de Tumores Digestivos #RETUD cohorte BTC correlación de PFS-OS: Estudio con la colaboración del grupo RETUD ➡️Correlación entre SLP y SG en pacientes con cáncer de la vía biliar avanzado que reciben tratamiento sistémico antitumoral 🧵(1/2) #ESMOGI24

Un logro de todo el equipo multidisciplinar de #pancreascancer de nuestro Hospital Vall d'Hebron, para y por nuestros pacientes y sus familias. Seguimos luchando por ello. Teresa Macarulla Florian Castet laiablanco Piero Alberti Vall d’Hebron Institute of Oncology (VHIO) Vall d'Hebron Institut de Recerca #locallyadvancedPDAC #BRPDAC AESPANC

Finally out the printed version of our single cell atlas of the entire murine ductal tree gastrojournal.org/article/S0016-… Followed by a really nice editorial from Rohit Chandwani gastrojournal.org/article/S0016-… Thanks to all the collaborators Jennifer Bailey-Lundberg lorenzopasquali Miltenyi Biotec

Clinical Value of Liquid Biopsy in FGFR2+ CCA During Targeted Therapy Clinical Cancer Research doi.org/10.1158/1078-0… 👉90% of FGFR2 fusion are detectable by ctDNA 👉⬆️level correlate w/ worse outcome & impaired liver function 👉good correlation w/ response & PD 👉Polyclonal resistence w/

Primer preceptorship en Hepatocarcinoma al Hospital Universitari Bellvitge | HUB !! Benvinguts!! Maria Rosa Rota Roca Mariona Jose Castellote

We’re looking for a passionate PhD fellow to join our #VHIO team in cutting-edge #TranslationalResearch on #biliarytractcancer. Fully funded #FPI fellowship available! visit vhio.net/vhio-phd-oppor… #PhD #ScienceJobs #Oncology #cholangiocarcinoma

Immunotherapy for hepatocellular carcinoma ➡️The next evolution in expanding access to liver transplantation Read it here👉journal-of-hepatology.eu/article/S0168-… Michael Li, MD, MPH #LiverTwitter

KRAS inhibitors are a game changer esp in pancreatic cancer. Exciting tolerability and efficacy of KRAS(on) inhibitor RMC-6236 presented by David S. Hong MD #ENAsymp24. Registrational PIII trial open: clinicaltrials.gov/study/NCT06625…. Our internal waitlists for these studies ⬆️.

In a phase 2 trial, researchers examined the safety and efficacy of the monoclonal antibody ponsegromab for treating cancer cachexia. Full trial results and Plain Language Summary: nej.md/3XE645a

Alison Schram, MD, details data from the eNRGy study that supported the FDA approval of zenocutuzumab in NRG1 fusion–positive NSCLC and pancreatic adenocarcinoma. Memorial Sloan Kettering Cancer Center #lcsm #pancsm #oncology #MedTwitter hubs.li/Q034Ys8g0

📢 Día Mundial del Cáncer: 8 expertos analizan una década de avances en oncología 🩺✨ En OncoBites, reunimos a ocho líderes de opinión en oncología de España para conocer su visión sobre la evolución del diagnóstico y tratamiento del cáncer en los últimos 10 años. 👨‍⚕️👩‍⚕️ Sus

Lifestyle is a stronger predictor of aging and mortality than genetics. A new Nature study of ~500,000 people found: 🎯 17% of mortality variation was linked to lifestyle (exposome). 🧬 <2% of was explained by genetics. Here’s what you need to know 👇🧵 1/10

📌In our March issue Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

🚨 We'are thrilled to share our last study in colab with Gabriel Rabinovich, Juan L. Iovanna & Martin Fernandez-Zapico Lab that reveals a nuclear role for Galectin-1 (Gal1) in pancreatic stellate cells (PSCs), directly regulating KRAS expression and reshaping the PDAC stroma. A thread! 🧵👇 PNASNews #PDAC

Genomic profiling unlocks new treatment opportunities for ampullary carcinoma in ESMO Open. Retrospective analysis showing over 50% of cases with actionable alterations, some responding to personalized therapies. esmoopen.com/article/S2059-…